Mount Sinai Unveils New Center for AI-Driven Small Molecule Drug Discovery
The Icahn School of Medicine at Mount Sinai has embarked on a transformative venture with the launch of its AI...
Iris M. reports on pharmacology and drug discovery, tracking therapeutic targets, preclinical findings, clinical candidates, safety signals, and new treatment strategies.
The Icahn School of Medicine at Mount Sinai has embarked on a transformative venture with the launch of its AI...
In the realm of modern chemistry and drug development, the innovative field of biomimetic synthesis has emerged as a pivotal...
A groundbreaking study published in Nature Communications reveals the immense potential of computer algorithms in the quest for new anti-inflammatory...
The Arizona Board of Regents' decision on February 14 marks a significant advancement in the educational landscape of the state...
In a groundbreaking study published in the Journal of Controlled Release, researchers at the Technion-Israel Institute of Technology are heralding...
A recent study has unveiled troubling insights regarding the co-prescription of central nervous system stimulants alongside opioid medications, particularly highlighting...
Drug discovery remains one of the most daunting and expensive challenges in the pharmaceutical industry. Central to this process is...
The successful delivery of therapeutics hinges on the ability to navigate complex biological barriers that safeguard cells from harmful substances,...
Scientists affiliated with Trinity College Dublin have achieved a significant milestone in the field of chemistry, addressing one of the...
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital have found a new method to increase...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine